Yahoo

For decades, people with severe alopecia areata had no approved treatment options. Until now.

For Christian Daniels, it started when his co-worker pointed out a dime-sized bald patch on the back of his head. Within days, he was waking up each morning to find clumps of hair on his white ...
St. Louis American

People Living with Severe Alopecia Areata, It’s Time to Talk to Your Doctor

For many people, alopecia areata presents as small, well-defined patches of hair loss on the scalp. But for others with severe cases, the unpredictable autoimmune disease can progress to a complete ...
TipRanks on MSN

Almirall advances LAD603 phase 2 alopecia trial, adding optionality to its dermatology pipeline

Almirall SA ($GB:0O9B) announced an update on their ongoing clinical study. Study Overview: Almirall S.A. is running a phase 2 trial called “A ...
clinicaladvisor.com

Olumiant Approved for Severe Alopecia Areata

The approval was based on data from the phase 2/3 BRAVE-AA1 and phase 3 BRAVE-AA2 trials, which included adults with severe alopecia areata. The Food and Drug Administration (FDA) has approved ...
Monthly Prescribing Reference

Rezpegaldesleukin Fast Tracked for Severe to Very Severe Alopecia Areata

Nektar Therapeutics is expected to announce topline data from the REZOLVE-AA trial in December 2025. The Food and Drug Administration (FDA) has granted Fast Track designation to rezpegaldesleukin for ...
Monthly Prescribing Reference

Leqselvi Now Available for Severe Alopecia Areata

Credit: SUN Pharma. Leqselvi is supplied as a tablet containing 8mg of deuruxolitinib. Prior to initiating treatment with Leqselvi, certain evaluations and immunizations are recommended. Leqselvi ™ ...
Yahoo

FDA approves 1st treatment that can grow back hair for teens with severe alopecia areata

The U.S. Food and Drug Administration on Friday approved an alopecia treatment for kids, marking a historic first. The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severe ...
The American Journal of Managed Care

Hair Regrowth in Severe Alopecia Areata Improves Quality of Life While Reducing Anxiety, Depression

People with alopecia areata who experience hair regrowth may also see improvements in their quality of life and mental health, according to a new study. A post hoc study conducted in adults with ...
The American Journal of Managed Care

Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss

Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...
Healio

Withdrawing baricitinib treatment for severe alopecia areata results in loss of benefit

Please provide your email address to receive an email when new articles are posted on . By week 152, 80% of patients who were withdrawn from baricitinib therapy lost their hair again vs. only 7% of ...
MedPage Today

First Oral JAK Inhibitor Approved for Severe Alopecia Areata in Teens

The FDA approved the Janus kinase (JAK) inhibitor ritlecitinib (Litfulo) for adults and adolescents with severe alopecia areata. Ritlecitinib is the second oral JAK inhibitor approved for alopecia ...

Nektar Study Establishes Proof-of-Concept in Patients with Severe Alopecia Areata

Nektar Therapeutics released data from a study of its rezpegaldesleukin drug, establishing proof-of-concept in patients with severe to very severe alopecia areata, a hair-loss condition.